CSRC Audit Halts Unitree’s STAR Market IPO, Slashing Valuation and AI Funding

The China Securities Regulatory Commission (CSRC) has targeted robotics manufacturer Unitree Technology Co., Ltd. for a randomized on-site audit, effectively pausing its STAR Market IPO for an estimated 90 days. This regulatory scrutiny threatens to gut Unitree’s pre-IPO valuation. While CITIC Securities initially projected a range of 50.6 billion to 55.9 billion yuan, institutional inquiries now point to a valuation of under 38 billion yuan.

Market participants previously viewed Unitree’s registration filing as the launchpad for an expedited listing. However, an official on-site inspection immediately suspends the regulatory review clock. Inspectors are currently reviewing physical inventory, bank records, and customer contracts at Unitree’s Hangzhou facilities.

How the CSRC Audit Derails Unitree’s Listing Timeline

Regulatory disclosure logs from the Shanghai Stock Exchange show a clear pattern: of the 42 STAR Market candidates selected for CSRC on-site reviews between 2024 and 2026, 78% (33 companies) either slashed their initial fundraising targets or faced listing delays exceeding 90 days.

Historical data reveals that hardware and artificial intelligence startups experience an average 22% valuation drop from lead underwriter estimates following these audits. Applying this baseline haircut to CITIC Securities’ 50.6 billion yuan lower-bound estimate reduces Unitree’s valuation to roughly 39.4 billion yuan. When regulatory delays drag past three months, institutional investors routinely demand steeper pricing concessions.

Scrutinizing State-Subsidized Revenue Streams

Regulators initiated the audit to determine whether Unitree’s reported top-line growth stems from sustainable commercial demand or relies heavily on state-funded academic grant programs.

Unitree’s IPO prospectus reported an operating revenue of 1.708 billion yuan in 2025—a massive 335% year-over-year surge, with gross profit margins holding above 60%. However, 73.6% of Unitree’s humanoid robot revenue came directly from academic research laboratories and state-funded universities. In 2025, universities accounted for 4,048 of the 5,500 units shipped, while industrial enterprise clients made up just 9% of total shipments.

Procurement records confirm these university purchases relied almost exclusively on state research grants from the National Natural Science Foundation of China. CSRC auditors will assess whether this purchasing pattern represents viable, recurring commercial demand. Furthermore, while Unitree reported a statutory net profit of 287.6 million yuan for 2025, its adjusted net profit reached 600.1 million yuan—a figure heavily inflated by government research tax credits and local software subsidies.

CITIC Securities’ Valuation Target vs. Institutional Pricing

Lead sponsor CITIC Securities targeted a post-listing valuation above 50 billion yuan, representing roughly 30 times the company’s 2025 sales. Following the audit notification, institutional buyers are aggressively lowering their bids.

Preliminary price inquiry data on the Shanghai Stock Exchange e-IPO platform indicates private fund managers have adjusted their subscription ranges to between 35 billion and 38 billion yuan. CITIC Securities has declined to comment on its valuation methodology. A Unitree representative described the inspection as a standard procedural component of China’s registration-based IPO framework.

The Direct Hit to Unitree’s Embodied AI Roadmap

A slashed IPO valuation directly reduces net proceeds, creating an estimated 840.4 million yuan funding gap that will force Unitree to scale back its AI development programs.

Unitree’s prospectus outlined an initial plan to raise 4.202 billion yuan, allocated across three primary areas:

• 2.00 billion yuan: Embodied AI model training clusters and dataset acquisition.
• 1.20 billion yuan: Next-generation humanoid robot mass production facilities.
• 1.002 billion yuan: Working capital and global distribution expansion.

A 20% reduction in final issuance pricing drops the total capital raised to 3.361 billion yuan. Under the prospectus’s capital allocation formulas, this shortfall slashes the dedicated embodied AI model budget from 2.00 billion yuan to 1.16 billion yuan. This 42% reduction in essential computing cluster capital will directly impede the company’s ability to scale complex AI models.

Frequently Asked Questions

What does the CSRC on-site audit mean for Unitree’s IPO?

The CSRC on-site audit involves a physical inspection of Unitree Technology’s financial records, sales contracts, and manufacturing facilities. This halts the listing review clock, allowing regulators to investigate whether the company’s 335% revenue growth relies disproportionately on state-funded university grants rather than commercial enterprise demand.

What is Unitree’s expected valuation in its STAR Market IPO?

While sponsor CITIC Securities initially projected a valuation between 50.6 billion and 55.9 billion yuan, historical audit precedents and current institutional inquiries point to a heavily revised market valuation between 35 billion and 38 billion yuan.

How will an IPO valuation cut affect Unitree’s technology roadmap?

A 20% reduction in IPO proceeds creates an 840.4 million yuan funding deficit. This shortfall forces Unitree to cut its planned 2.00 billion yuan budget for embodied AI model training clusters down to 1.16 billion yuan, severely restricting its capacity to scale physical AI simulations that rely on high-end hardware accelerators.